AOD-9604 Peptide Therapy

AOD-9604 is a modified fragment of human growth hormone (HGH) designed to promote fat metabolism without the growth-promoting side effects of full-length HGH. Originally developed as a potential anti-obesity treatment, AOD-9604 has gained attention in the fields of weight management and wellness for its ability to support fat loss, improve metabolism, and potentially protect cartilage health. At The Catalyst Clinic, we provide expert guidance and medical supervision for peptide therapy, including AOD-9604.

What is AOD-9604?

AOD-9604 is a synthetic peptide derived from amino acids 176–191 of the HGH molecule — the portion believed to be responsible for its fat-burning effects.

  • Lipolysis stimulation – encourages fat breakdown for energy

  • Inhibition of lipogenesis – helps prevent the formation of new fat stores

  • No growth promotion – does not stimulate unwanted bone or cartilage growth, unlike full HGH

  • No IGF-1 increase – unlike HGH, it does not significantly elevate insulin-like growth factor 1 (IGF-1)

In plain terms: AOD-9604 is a peptide designed to target fat metabolism only, making it a focused option for those exploring weight management support.

Benefits of AOD-9604

Research and clinical interest suggest that AOD-9604 may:

  • • Promote fat loss – particularly around the abdominal region
  • • Support weight management – by balancing fat storage and fat burning
  • • Improve lipid profile – potential positive effects on cholesterol and blood lipids
  • • Avoid blood sugar disruption – no consistent negative impact on glucose or insulin sensitivity
  • • Protect cartilage – early studies suggest possible cartilage-protective and regenerative effects

How AOD-9604 Works

AOD-9604 works by mimicking the fat-regulating actions of natural HGH:

  • • Stimulates lipolysis – breaking down stored fat into fatty acids for energy
  • • Inhibits lipogenesis – reducing the body’s tendency to store new fat
  • • Enhances fatty acid oxidation – encouraging the body to use fat for fuel

Unlike HGH, AOD-9604 does not promote tissue growth, making it a potentially safer option for weight and metabolism support.

Potential Therapeutic Applications

AOD-9604 has been studied for:

  • • Weight management – supporting fat loss programmes
  • • Obesity treatment – explored in clinical trials as a therapeutic option
  • • Cartilage protection – potential role in joint health and repair (early-stage research)
  • • Metabolic support – improving lipid and energy balance

Note: AOD-9604 remains investigational outside specific approved uses and should only be used under professional supervision.

Administration

Typical method: Subcutaneous injection (under the skin)

  • • Dosage: Often reported between a few hundred micrograms to 1mg per day
  • • Frequency: Usually once or twice daily, depending on protocol

Optimal dosage is still under research and should be tailored individually by a medical professional.

Safety and Side Effects

AOD-9604 is generally well tolerated. Reported side effects are mild and usually temporary:

  • • Redness at injection site
  • • Swelling
  • • Itching
  • • Bruising

Unlike HGH, AOD-9604 has not been consistently linked to changes in blood sugar levels, growth abnormalities, or systemic side effects.

Treatment Process at The Catalyst Clinic

1

Consultation

Review of your medical history and health goals.

2

Personalised Plan

If appropriate, AOD-9604 may be included in your peptide therapy programme.

3

Ongoing Monitoring

Regular check-ups ensure safety and track results.

Our clinics in London, New York, and Zurich provide advanced peptide therapies with expert medical support.

 FAQs

  • It is primarily researched for fat reduction, weight management, and potential cartilage protection.

  • It is a fragment of HGH that focuses on fat metabolism only, without growth-promoting effects.

  • Studies suggest it is generally well tolerated, with mild side effects limited to injection site reactions.

  • Yes. The Catalyst Clinic offers consultations and supervised peptide therapy including AOD-9604 at our London clinic.

Book a Consultation

Looking to explore AOD-9604 peptide therapy for weight management?
Contact The Catalyst Clinic in London, New York, or Zürich today to book your consultation.